Put Skin Cancer Risk With Hydrochlorothiazide in Perspective
Patients will ask you if they should stop hydrochlorothiazide...based on new labeling that points out increased skin cancer risk.
Growing evidence suggests a link between hydrochlorothiazide and nonmelanoma skin cancer...mostly squamous cell carcinoma.
Photosensitivity with hydrochlorothiazide may play a role.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote